23andMe Holding Co - Ordinary Shares - Class A Aktie News
0,50 $
0,38 %
gestern
Nasdaq,
1. Mai, 22:00 Uhr
tracken
23andMe Holding Co - Ordinary Shares - Class A Aktie News
Neutral
Business Wire
●
ein Tag alt
SAN FRANCISCO--(BUSINESS WIRE)--Potter Handy LLP, a leading consumer privacy law firm, today announced that it is representing nearly 5,000 individuals in California and Illinois impacted by the massive data breach at genetic testing company 23andMe (NASDAQ: ME). In October 2023, 23andMe revealed that an unauthorized third party had gained access to the accounts of approximately seven million c...
Neutral
GlobeNewsWire
●
7 Tage alt
Data from neuroendocrine and ovarian cancer patient cohorts in the Phase 1/2a clinical trial of 23ME-00610 to be presented Data from neuroendocrine and ovarian cancer patient cohorts in the Phase 1/2a clinical trial of 23ME-00610 to be presented
Positiv
The Motley Fool
●
9 Tage alt
Matterport is being acquired by CoStar in a $1.7 billion cash and stock deal. The company not only has an excellent proprietary technology, but also a strong balance sheet.
Negativ
Fast Company
●
13 Tage alt
Like a number of companies that went public during the pandemic, 23andMe has for months been trying to manage a terrible case of SPAC-itis, an inflammation that causes plunging stock values due to the business being, as one analyst put it, not “ready for prime time.”
Positiv
Proactive Investors
●
13 Tage alt
23andMe Holding Co.'s shares surged after CEO Anne Wojcicki revealed plans to potentially take the struggling DNA testing firm private. The announcement follows the company's dismal performance since going public three years ago, with shares plummeting by over 90% amid sluggish adoption of its personalized DNA services.
Positiv
InvestorPlace
●
13 Tage alt
23andMe (NASDAQ: ME ) stock is on the move Thursday after CEO Anne Wojcicki proposed taking the consumer genetics testing company private. A filing with the Securities and Exchange Commission (SEC) reveals that Wojcicki notified members of the Board of Directors Special Committee about such a plan on April 13.
Positiv
Investopedia
●
13 Tage alt
23andMe (ME) chief executive Anne Wojcicki is seeking to take the DNA-testing company private less than three years after it went public, the firm said in a Securities and Exchange Commission (SEC) filing.
Positiv
CNBC
●
13 Tage alt
23andMe CEO Anne Wojcicki is considering a proposal to take the genetic testing company private
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
